Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation
PHASE2CompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
November 30, 1997
Primary Completion Date
December 31, 2000
Conditions
Lymphoma
Interventions
DRUG
Amifostine
DRUG
DHAP
Trial Locations (1)
90095-1781
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
All Listed Sponsors
lead
Jonsson Comprehensive Cancer Center
OTHER
NCT00003143 - Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation | Biotech Hunter | Biotech Hunter